A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse

被引:135
作者
Aubin, I
Adams, CP
Opsahl, S
Septier, D
Bishop, CE
Auge, N
Salvayre, R
Negre-Salvayre, A
Goldberg, M
Guénet, JL
Poirier, C
机构
[1] Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France
[2] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA
[3] Univ Paris 05, Fac Chirurg Dent, EA 2496, F-92120 Montrouge, France
[4] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[5] CHU Rangueil, INSERM, U466, F-31059 Toulouse, France
[6] CHU Rangueil, Dept Biochem, IFR 31, F-31059 Toulouse, France
关键词
D O I
10.1038/ng1603
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The mouse mutation fragilitas ossium (fro) leads to a syndrome of severe osteogenesis and dentinogenesis imperfecta with no detectable collagen defect. Positional cloning of the locus identified a deletion in the gene encoding neutral sphingomyelin phosphodiesterase 3 (Smpd3) that led to complete loss of enzymatic activity. Our knowledge of SMPD3 function is consistent with the pathology observed in mutant mice and provides new insight into human pathologies.
引用
收藏
页码:803 / 805
页数:3
相关论文
共 14 条
[1]   Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein [J].
Augé, N ;
Escargueil-Blanc, I ;
Lajoie-Mazenc, I ;
Suc, I ;
Andrieu-Abadie, N ;
Pieraggi, MT ;
Chatelut, M ;
Thiers, JC ;
Jaffrézou, JP ;
Laurent, G ;
Levade, T ;
Nègre-Salvayre, A ;
Salvayre, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :12893-12900
[2]   Osteogenesis imperfecta: Prospects for molecular therapeutics [J].
Forlino, A ;
Marini, JC .
MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) :225-232
[3]   Osteogenesis imperfecta type VI: A form of brittle bone disease with a mineralization defect [J].
Glorieux, FH ;
Ward, LM ;
Rauch, F ;
Lalic, L ;
Roughley, PJ ;
Travers, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (01) :30-38
[4]   Type V osteogenesis imperfecta: A new form of brittle bone disease [J].
Glorieux, FH ;
Rauch, F ;
Plotkin, H ;
Ward, L ;
Travers, R ;
Roughley, P ;
Lalic, L ;
Glorieux, DF ;
Fassier, F ;
Bishop, NJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (09) :1650-1658
[5]  
Goldberg M, 1996, PROG HISTOCHEM CYTOC, V31, P1
[6]   Sphingomyelinases:: enzymology and membrane activity [J].
Goñi, FM ;
Alonso, A .
FEBS LETTERS, 2002, 531 (01) :38-46
[7]   Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate [J].
Grey, A ;
Xu, X ;
Hill, B ;
Watson, M ;
Callon, K ;
Reid, IR ;
Cornish, J .
CALCIFIED TISSUE INTERNATIONAL, 2004, 74 (06) :542-550
[8]   FRAGILITAS OSSIUM - A NEW AUTOSOMAL RECESSIVE MUTATION IN THE MOUSE [J].
GUENET, JL ;
STANESCU, R ;
MAROTEAUX, P ;
STANESCU, V .
JOURNAL OF HEREDITY, 1981, 72 (06) :440-441
[9]   MORPHOLOGICAL AND BIOCHEMICAL-STUDIES OF A MOUSE MUTANT (FRO/FRO) WITH BONE FRAGILITY [J].
MURIEL, MP ;
BONAVENTURE, J ;
STANESCU, R ;
MAROTEAUX, P ;
GUENET, JL ;
STANESCU, V .
BONE, 1991, 12 (04) :241-248
[10]   FRAGILITAS-OSSIUM (FRO/FRO) IN THE MOUSE - A MODEL FOR A RECESSIVELY INHERITED TYPE OF OSTEOGENESIS IMPERFECTA [J].
SILLENCE, DO ;
RITCHIE, HE ;
DIBBAYAWAN, T ;
ETESON, D ;
BROWN, K .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1993, 45 (02) :276-283